Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (noted as Mbody AI Ltd. in request metadata) covers the period of September 1, 2021. The registrant is a foreign private issuer based in Isfiya, Israel, filing under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements.
Material Changes
The primary material change disclosed is a leadership transition within the clinical affairs department:
- Dr. Hanit Brenner-Lavie was appointed as Vice President of Clinical Affairs effective September 1, 2021.
- Dr. Brenner-Lavie is replacing Dr. Vardit Segal in this role.
Guidance, Outlook, and Risks
The filing incorporates by reference the "Forward Looking Statements" from the attached press release (Exhibit 99.1) into specific Post-Effective Amendments and Registration Statements (File Nos. 333-203384, 333-226490, 333-211065, and 333-225789). The text of this specific Form 6-K does not detail specific guidance, risks, or contingencies beyond the appointment announcement.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for details on Dr. Brenner-Lavie's background and the strategic rationale for the appointment.
- Review the incorporated "Forward Looking Statements" in the referenced Registration Statements for updated risk factors or outlook.
- Confirm the departure details of Dr. Vardit Segal to understand the scope of the transition.